Estrogen receptor (ER)‐positive breast cancer patients have a steady long‐term risk of fatal disease, and distant metastatic recurrence can occur anywhere between a few months to several decades after primary diagnosis.1, 2, 3, 4, 5, 6. This evidence concerns the gene ESR1 and breast cancer.